Telehealth Treatment of Veterans With Alcohol Misuse at Risk for Cardiovascular Disease (CDA 19-035)
Sponsor: VA Office of Research and Development
Trial Details
| Condition | Alcohol Misuse, Hypertension, Elevated Cardiovascular Risk |
| Intervention | Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM) |
| Phase | NA |
| Status | Completed |
| Participants | 30 |
| Est. Completion | 30 May 2025 |
| Last Updated | 29 May 2026 |
Primary Outcome
Enrollment Feasibility; Treatment Feasibility; Treatment Acceptability; Therapist Fidelity; SMS Text Acceptability
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Enrolled in 1 of 3 primary care clinics associated with the Durham VAHCS, as evidenced by at least one outpatient PCP visit recorded in Managerial Cost Accounting (MCA) system. * Diagnosis of hypertension, hyperlipidemia, and/or diabetes mellitus in EHR (ICD-10 codes I10, E78.xx, and E11.xxxx) for at least one year. * Uncontrolled BP (indicated by average outpatient past year systolic BP of \>140/100mmHg). \> 1 measurement required. * Currently prescribed at least one oral medication for hypertension, hyperlipidemia, and/or diabetes mellitus as evidenced by at least one pharmacy refill within the previous year. * Most recent EHR AUDIT-C 5 (suggestive of alcohol misuse). * Self-reported access to any SMS text-capable phone. * Appropriate medication regimen for CVD prevention, screened by research coordinator and reviewed by Matt Crowley, MD (Mentor). Exclusion Criteria: * Current enrollment in another trial for CVD risk reduction or medication adherence specifically. * Current participation in other alcohol misuse treatment programming. * EHR AUDIT-C suggestive of severe alcohol dependence requiring medical treatment, defined as 10-12 for both men and women. * Any recent or impending procedures that would warrant inpatient hospital stays or considerable changes to current medications (e.g., any changes other than altered doses). * Current palliative care or care through a nursing/hospice home. * History of clinically significant alcohol withdrawal symptoms, as evidenced by a score 10 on the CIWA. * Contraindicated medication regimen for CVD prevention, screened by research coordinator and reviewed by Matt Crowley, MD (Mentor).
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service